| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rennie L Rhee, Ryan Rebello, Madhura A Tamhankar, Shubhasree Banerjee, Fang Liu, Quy Cao, Robert Kurtz, Joshua F Baker, Zhaoyang Fan, Vatsal Bhatt, Naomi Amudala, Sherry Chou, Rui Liang, Marisa Sanchez, Morgan Burke, Lisa Desiderio, Laurie A Loevner, Jeffrey S Morris, Peter A Merkel, Jae W Son. Combined Orbital and Cranial Vessel Wall Magnetic Resonance Imaging for the Assessment of Disease Activity in Giant Cell Arteritis. ACR open rheumatology. 2024-01-24. PMID:38265177. |
acute visual impairment is the most feared complication of giant cell arteritis (gca) but is challenging to predict. |
2024-01-24 |
2024-01-26 |
Not clear |
| Pascal Seitz, Jennifer Cullmann, Susana Bucher, Lukas Bütikofer, Stephan Reichenbach, Fabian Lötscher, Jennifer Amsler, Lisa Christ, Harald M Bonel, Peter M Villiger, Luca Seit. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica. Rheumatology (Oxford, England). 2024-01-24. PMID:38265241. |
to investigate the proportion and distribution of contrast enhancement (ce) of musculoskeletal structures with mri of the thorax/abdomen/pelvis in giant cell arteritis (gca). |
2024-01-24 |
2024-01-26 |
Not clear |
| Menglin Wu, Zhixiong Liao, Kaidong Zeng, Qiaohui Jian. Exploring the causal role of gut microbiota in giant cell arteritis: a Mendelian randomization analysis with mediator insights. Frontiers in immunology. vol 14. 2024-01-19. PMID:38239360. |
giant cell arteritis (gca) is a complex autoimmune condition. |
2024-01-19 |
2024-01-21 |
Not clear |
| Claus-Jürgen Bauer, Valentin Sebastian Schäfe. [Diagnostics and treatment of large vessel vasculitis]. Innere Medizin (Heidelberg, Germany). 2024-01-19. PMID:38240814. |
giant cell arteritis (gca) and takayasu arteritis (tak), as the main representatives of large vessel vasculitis, are rheumatological autoimmune disorders associated with inflammatory vessel wall changes in the arterial system that can lead to many types of organ damage. |
2024-01-19 |
2024-01-21 |
Not clear |
| Lena Kreis, Christian Dejaco, Wolfgang Andreas Schmidt, Robert Németh, Nils Venhoff, Valentin Sebastian Schäfe. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study. Trials. vol 25. issue 1. 2024-01-15. PMID:38225579. |
glucocorticoids (gc) are the standard treatment for giant cell arteritis (gca), even though they are associated with adverse side effects and high relapse rates. |
2024-01-15 |
2024-01-18 |
Not clear |
| L Goncalves, V-T Tran, J Chauffier, V Bourdin, K Nassarmadji, A Vanjak, W Bigot, R Burlacu, K Champion, A Lopes, A Depont, B A Borrero, O Mangin, H Adle-Biassette, P Bonnin, A Boutigny, S Bonnin, L Neumann, S Mouly, D Sène, C Comarmon. [Clinical characteristics and follow-up of 60 patients with recent diagnosis of giant cell arteritis, NEWTON study]. La Revue de medecine interne. 2024-01-12. PMID:38216390. |
the management of giant cell arteritis (gca) has evolved with the arrival of tocilizumab (tcz) and the use of pet/ct. |
2024-01-12 |
2024-01-15 |
Not clear |
| Pieter H Nienhuis, Marieke van Nieuwland, Gijs D van Praagh, Karolina Markusiewicz, Edgar M Colin, Kornelis S M van der Geest, Nils Wagenaar, Elisabeth Brouwer, Celina Alves, Riemer H J A Slar. Comparing Diagnostic Performance of Short and Long [ Diagnostics (Basel, Switzerland). vol 14. issue 1. 2024-01-11. PMID:38201371. |
comparing diagnostic performance of short and long [ (1) background: in giant cell arteritis (gca), the assessment of cranial arteries using [ |
2024-01-11 |
2024-01-13 |
Not clear |
| Jane Maestri Brittain, Michael Stormly Hansen, Jonathan Frederik Carlsen, Andreas Hjelm Brandt, Lene Terslev, Mads Radmer Jensen, Ulrich Lindberg, Henrik Bo Wiberg Larsson, Steffen Heegaard, Uffe Møller Døhn, Oliver Niels Klefter, Anne Katrine Wiencke, Yousif Subhi, Steffen Hamann, Bryan Haddoc. Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging. Diagnostics (Basel, Switzerland). vol 14. issue 1. 2024-01-11. PMID:38201390. |
in order to support or refute the clinical suspicion of cranial giant cell arteritis (gca), a supplemental imaging modality is often required. |
2024-01-11 |
2024-01-13 |
Not clear |
| Jérôme El Haddad, Frédérique Charbonneau, Jessica Guillaume, Gaëlle Clavel, Thibaud Chazal, Guillaume Poillon, Alexia Tran, Alexandre Niro, Rémi Sore, Luca Litman-Roventa, Kévin Mahe, Samantha Chhour, Julien Savatovsky, Augustin Lecle. Reproducibility and accuracy of vessel wall MRI in diagnosing giant cell arteritis: a study with readers of varying expertise. European radiology. 2024-01-11. PMID:38206404. |
to evaluate the reproducibility of vessel wall magnetic resonance imaging (vw-mri) in diagnosing giant cell arteritis (gca) among groups of radiologists with varying levels of expertise. |
2024-01-11 |
2024-01-13 |
Not clear |
| Konstanze V Guggenberger, Marius L Vogt, Jae W Song, Matthias Fröhlich, Marc Schmalzing, Nils Venhoff, Rudolf Werner, Jost Hillenkamp, Mirko Pham, Stephan Meckel, Thorsten A Ble. High-resolution Magnetic Resonance Imaging visualizes intracranial large artery involvement in Giant Cell Arteritis. Rheumatology (Oxford, England). 2024-01-10. PMID:38197587. |
giant cell arteritis (gca) is a large vessel vasculitis, typically involving the aorta and its branches with predilection for the scalp arteries. |
2024-01-10 |
2024-01-13 |
Not clear |
| Marjan Khan, Abdul Subhan Talpur, Chady Abboud Leo. A Rare Case of Giant Cell Arteritis After the Administration of Checkpoint Inhibitor Therapy in a Metastatic Renal Cell Carcinoma Patient. Cureus. vol 15. issue 12. 2024-01-08. PMID:38186407. |
we present a rare case of metastatic renal cell carcinoma in a patient who developed giant cell arteritis (gca) after the administration of checkpoint inhibitor therapy with nivolumab and ipilimumab. |
2024-01-08 |
2024-01-10 |
Not clear |
| Pratheeshaa Nageswaran, Saad Ahmed, Hasan Tahi. Review of phase 2/3 trials in Polymyalgia Rheumatica and giant cell arteritis. Expert opinion on emerging drugs. 2024-01-05. PMID:38180809. |
gca (giant cell arteritis) and pmr (polymyalgia rheumatica) are two overlapping inflammatory rheumatic conditions that are seen exclusively in older adults, sharing some common features. |
2024-01-05 |
2024-01-08 |
Not clear |
| Jörg Henes, Jutta G Richter, Katja Thiele, Uta Kiltz, Johanna Callhoff, Katinka Albrech. Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021. Rheumatology international. 2024-01-05. PMID:38180499. |
the aim of this study is to present the current care situation of patients with giant cell arteritis (gca), takayasu arteritis (tak), anca-associated vasculitis (aav) and behçet's disease (bd). |
2024-01-05 |
2024-01-07 |
Not clear |
| Mayu Yamashita, Akiko Aoki, Hiroshi Kobayashi, Midori Wakiya, Munehide Nakatsugaw. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. vol 60. issue 4. 2024-01-03. PMID:38171762. |
giant cell arteritis (gca) is closely associated with polymyalgia rheumatica (pmr). |
2024-01-03 |
2024-01-06 |
Not clear |
| Saleh Alhawiti, Toka AlSulai. Orbital MRI Findings in a Patient With Giant Cell Arteritis (GCA): A Case Report. Cureus. vol 15. issue 11. 2023-12-28. PMID:38152789. |
orbital mri findings in a patient with giant cell arteritis (gca): a case report. |
2023-12-28 |
2023-12-30 |
Not clear |
| Saleh Alhawiti, Toka AlSulai. Orbital MRI Findings in a Patient With Giant Cell Arteritis (GCA): A Case Report. Cureus. vol 15. issue 11. 2023-12-28. PMID:38152789. |
giant cell arteritis (gca) is a medium- and large-vessel systemic vasculitis. |
2023-12-28 |
2023-12-30 |
Not clear |
| H K Skaug, B T Fevang, J Assmus, A P Diamantopoulos, G Myklebust, L K Brekk. Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013-2020. Frontiers in medicine. vol 10. 2023-12-27. PMID:38148911. |
there is an increasing awareness of the spectrum of phenotypes in giant cell arteritis (gca). |
2023-12-27 |
2023-12-29 |
Not clear |
| Kiyomi Yoshimoto, Saori Kaneda, Moe Asada, Hiroyuki Taguchi, Hiromasa Kawashima, Ryo Yoneima, Hidetoshi Matsuoka, Emiko Tsushima, Shiro Ono, Masaki Matsubara, Noritaka Yada, Kenji Nishi. Giant Cell Arteritis after COVID-19 Vaccination with Long-Term Follow-Up: A Case Report and Review of the Literature. Medicina (Kaunas, Lithuania). vol 59. issue 12. 2023-12-23. PMID:38138230. |
giant cell arteritis (gca) is a chronic vasculitis that primarily affects the elderly, and can cause visual impairment, requiring prompt diagnosis and treatment. |
2023-12-23 |
2023-12-25 |
Not clear |
| Mickael Bonnan, Stephane Debeugn. Giant-cell arteritis related strokes: scoping review of mechanisms and rethinking treatment strategy? Frontiers in neurology. vol 14. 2023-12-22. PMID:38130834. |
stroke is a rare and severe complication of giant cell arteritis (gca). |
2023-12-22 |
2023-12-24 |
Not clear |
| Cong-Qiu Ch. Advances and challenges in management of large vessel vasculitis. Rheumatology and immunology research. vol 4. issue 4. 2023-12-21. PMID:38125643. |
recent introduction of interleukin-6 signaling blocker, tocilizumab has substantially changed the practice in management of patients with lvv, in particular, giant cell arteritis (gca). |
2023-12-21 |
2023-12-23 |
Not clear |